Edition:
India

Thermo Fisher Scientific Inc (TMO.N)

TMO.N on New York Stock Exchange

192.27USD
15 Dec 2017
Change (% chg)

$3.95 (+2.10%)
Prev Close
$188.32
Open
$190.11
Day's High
$192.66
Day's Low
$189.41
Volume
1,707,899
Avg. Vol
447,904
52-wk High
$201.20
52-wk Low
$139.88

Chart for

About

Thermo Fisher Scientific Inc. develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical... (more)

Overall

Beta: 1.08
Market Cap(Mil.): $77,069.81
Shares Outstanding(Mil.): 398.89
Dividend: 0.15
Yield (%): 0.31

Financials

BRIEF-Thermo Fisher Scientific Acquires Continuous Emission Monitoring Assets From Eptek Technology

* THERMO FISHER SCIENTIFIC ACQUIRES CONTINUOUS EMISSION MONITORING ASSETS FROM EPTEK TECHNOLOGY

04 Dec 2017

BRIEF-‍Thermo Fisher Scientific recommends shareholders reject mini-tender offer by TRC Capital Corp​

* ‍thermo Fisher Scientific recommends shareholders reject mini-tender offer by TRC Capital Corporation​

22 Nov 2017

BRIEF-Evoke Pharma signs commercial agreement with Thermo Fisher Scientific

* Announced selection of Patheon division of Thermo Fisher Scientific as commercial manufacturing partner for Gimoti​

09 Nov 2017

BRIEF-Thermo Fisher Scientific and Cellular Biomedicine announce partnership to develop manufacturing processes

* Thermo Fisher Scientific and Cellular Biomedicine Group announce strategic partnership to develop manufacturing processes

06 Nov 2017

BRIEF-Thermo Fisher enters agreement with Blueprint Medicines​

* Thermo Fisher Scientific Inc - ‍ expanded development of Oncomine Dx Target Test by entering into an agreement with Blueprint Medicines Corporation​

31 Oct 2017

Thermo Fisher tops profit estimates; raises full-year forecast

Oct 25 Thermo Fisher Scientific Inc, the world's largest maker of scientific instruments, on Wednesday reported a higher-than-expected quarterly profit, fueled by sales growth in all of its units and contributions from recent acquisitions.

25 Oct 2017

BRIEF-Thermo Fisher Scientific reports Q3 Adj EPS of $2.31

* Q3 GAAP earnings per share $1.34; Q3 adjusted earnings per share $2.31

25 Oct 2017

BRIEF-TETRAPHASE PHARMACEUTICALS APPOINTS KAM UNNINAYAR AS CFO

* TETRAPHASE PHARMACEUTICALS APPOINTS KAM UNNINAYAR AS CHIEF FINANCIAL OFFICER

16 Oct 2017

EU mergers and takeovers (Aug 25)

BRUSSELS, Aug 25 The following are mergers under review by the European Commission and a brief guide to the EU merger process:

25 Aug 2017

EU mergers and takeovers (Aug 24)

BRUSSELS, Aug 23 The following are mergers under review by the European Commission and a brief guide to the EU merger process:

24 Aug 2017

Earnings vs. Estimates